Attovia Therapeutics Secures $289 Million in Upsized IPO, Signifying Robust Biotech Market Recovery
Attovia Therapeutics, a burgeoning biotechnology firm focused on innovative antibody-drug technologies for skin disorders and...
Knowledge and News for the Global Fight Against Cancer.
Attovia Therapeutics, a burgeoning biotechnology firm focused on innovative antibody-drug technologies for skin disorders and...
The transition into the fourth grade is a traditional milestone for American elementary students, usually...
The landscape of pediatric oncology is facing a potential paradigm shift as Dr. John Lee...
The Cancer Research Institute (CRI) has proudly unveiled its 2026 class of Lloyd J. Old...
Expedition Therapeutics, a rapidly emerging biotechnology company focused on bringing innovative therapies to market, announced...
For the hundreds of thousands of individuals who have successfully navigated the grueling landscape of...
The Urgent Crisis in Pediatric Neuro-Oncology Pediatric high-grade gliomas represent one of the most daunting...
The biopharmaceutical landscape has recently been marked by a series of significant developments, including a...
In the personal sanctuary of a ten-year-old girl named Valerie, a specific piece of artwork...
New York, NY – August 4, 2026 – Pfizer Inc. today announced a significant expansion...